Robert Bradway is the Chairman and Chief Executive Officer of Amgen, a biotechnology company focused on serving patients with serious diseases through.
Robert Bradway is the Chairman and Chief Executive Officer of Amgen, a biotechnology company focused on serving patients with serious diseases through innovative medicines. He has led Amgen's strategy to advance first-in-class treatments addressing major unmet medical needs for over a decade. Bradway is recognized for his leadership in driving Amgen's growth and scientific innovation.
Full founder directory · Investor directory · Company funding database · Fundraising library